This finding was similar to a study by Rivoltini et al. who demonstrated significant increase in CD3+PD-1+ lymphocytes and PD-L1+ monocyte populations 1 month after TARE in 49 HCC patients [98]. This evidence concerns the gene CD274 and hepatocellular carcinoma.